|
Volumn 65, Issue SUPPL. 1, 2005, Pages 113-126
|
Potent acid inhibition: Summary of the evidence and clinical application
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTACID AGENT;
ANTIBIOTIC AGENT;
ESOMEPRAZOLE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP INHIBITOR;
RABEPRAZOLE;
STOMACH SECRETION INHIBITOR;
ACIDITY;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC THERAPY;
ANTIREFLUX OPERATION;
ASTHMA;
BARRETT ESOPHAGUS;
CANCER RISK;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC TEST;
DIARRHEA;
DIGESTIVE SYSTEM ULCER;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SAFETY;
ENDOSCOPIC SURGERY;
ERADICATION THERAPY;
ESOPHAGITIS;
EVIDENCE BASED MEDICINE;
EYE DISEASE;
FIRST PASS EFFECT;
FIRST TRIMESTER PREGNANCY;
GASTRODUODENAL ULCER;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL INFECTION;
HEADACHE;
HELICOBACTER PYLORI;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INHIBITION KINETICS;
INTERSTITIAL NEPHRITIS;
LARYNGITIS;
MAINTENANCE THERAPY;
METABOLIC CAPACITY;
PEPTIC ULCER;
PHARMACODYNAMICS;
PLASMA HALF LIFE;
QUALITATIVE ANALYSIS;
QUANTITATIVE ANALYSIS;
REVIEW;
SINGLE DRUG DOSE;
STATISTICAL SIGNIFICANCE;
STOMACH ACID SECRETION;
STOMACH CANCER;
STOMACH PH;
TACHYPHYLAXIS;
TOXIC HEPATITIS;
UPPER GASTROINTESTINAL BLEEDING;
HELICOBACTER PYLORI;
|
EID: 30344461281
PISSN: 00126667
EISSN: 00126667
Source Type: Journal
DOI: 10.2165/00003495-200565001-00015 Document Type: Review |
Times cited : (3)
|
References (0)
|